Longdom Group SA hosts 200+ leading international conferences and virtual events annually. It is instrumental in bringing together experts and learners from all over the globe for mutual growth and effective research-oriented discussions. As per the present market demand and growth in the field of Brain Disorder and Brain Injury, Longdom Conferences is hosting its 5th International Conference on Brain Disorder and Brain Injury. This is scheduled for September 25-27,2023 in Prague, Czech Republic. The field of Brain Disorder and Brain Injury is one of the crucial scientific subjects, which is continuously evolving and have placed many landmarks in different research and development sectors. These fields are Traumatic brain injury, Therapeutics, Social healthcare, drug discovery, Brain cancer, Paediatric Brain Disorder, and many other industrial areas. The Brain Conference 2023 extends immense pleasure in inviting you to join us at this conference. We aim to engage, empower, evolve, and explore knowledge among attendees from all levels of scientific research on Epidemiology. This Brain Disorder and Brain Injury conference will be focussing on the core knowledge and major advances in the rapidly emerging fields by attracting eminent scholars, experts, and professionals globally.
Session and Tracks
Track 1: Brain structure and its function
The session will begin with an overview of the structure and function of the brain, including a discussion of the different regions and structures that make up the brain, the role of neurons and synapses in transmitting information, and the importance of glial cells in supporting and protecting these cells.
Track 2: Pediatric Neurology
This conference session will focus on the challenges and recent advances in the field of pediatric neurology. The session will cover topics related to neurological disorders in children, including diagnosis, treatment, and management. Experts in the field will present their latest research findings and discuss the current state of knowledge in pediatric neurology
1. Diagnosis and management of epilepsy in children
2. Advances in the treatment of cerebral palsy
3. New insights into the genetic basis of pediatric neurological disorders
4. Diagnosis and management of pediatric migraine
5. Emerging therapies for neuromuscular disorders in children
The session is intended for pediatric neurologists, neurosurgeons, pediatricians, and other healthcare professionals who work with children with neurological disorders. Attendees will have the opportunity to learn about the latest research findings and interact with experts in the field.
Track 3: Advanced Trends in Brain
This session will focus on the advancements in technology used to diagnose and treat brain injuries. The presenter, a renowned neurologist, discusses the latest developments in imaging techniques and the growing role of artificial intelligence in analyzing brain scan data. The session will also emphasize the importance of early detection and intervention in brain injury cases.
Track 4: Brain Mapping
conference session on Brain Mapping was a fascinating continuation of the earlier presentation on brain disorders and injuries. The speakers will point out the latest advances in mapping techniques and how they're contributing to a better understanding of brain function and structure. They would highlight techniques such as magnetic resonance imaging (MRI), computed tomography (CT), electroencephalography (EEG), and positron emission tomography (PET), emphasizing how valuable these methods are to diagnosing and treating brain disorders and diseases.
Track 5: Neuro-oncology and Neuroscience
Moving on to a specific topic of the conference, the session on Neuro-oncology and brain cancer is particularly informative. World-renowned experts specializing in this field present their research, simultaneously elucidating the gravity of brain cancer as it stands today. Attendees will learn about the latest advancements in brain tumor management, the significant challenges faced when treating central nervous system malignancies, and most significantly novel therapeutic opportunities being evaluated or administrated in clinical trials. During this session, the research will be presenting profoundly demonstrated potential applications of developing personalized, innovative medical cancer treatments.
Track 6: Traumatic Brain Injury
The speaker will emphasize that several factors, such as falls, sports injuries, auto mishaps, and aggression, can lead to TBIs. They will clarify that a TBI can vary in intensity from moderate to severe and that its effects can be either short-term or long-term. The presenters stress that even mild TBIs can have an impact on a person's cognition, bodily functioning, emotions, and conduct. The difficulties involved in identifying and managing TBIs will also be discussed in the following session.
Track 7: Behaviour Science
It will be a thought-provoking and informative discussion on the study of human behavior and its applications in various fields. The session will cover a broad range of topics related to behavior science, including psychology, neuroscience, sociology, and anthropology. The speakers will highlight the importance of understanding human behavior to develop effective interventions and strategies for improving health, education, and social outcomes. They would discuss the various theories and models that have been developed to explain human behavior, including cognitive, social, and behavioral psychology.
Track 8: Brain Engineering
Overall, the conference session on Brain Engineering will be an exciting and thought-provoking discussion on the development of technologies and interventions aimed at enhancing brain function and performance. The session will also underscore the need for ongoing research, interdisciplinary collaboration, and ethical considerations in the development and application of brain engineering technologies.
Track 9: Dyslexia
The dyslexia conference session features an engaging and enlightening talk about the learning condition that impairs reading and writing abilities. The discussion at the conference will address a wide variety of dyslexia-related subjects, such as its causes, symptoms, and treatments. The presenters should make a point of pointing out that dyslexia is a neurological disorder that affects how the brain interprets words.
Track 10: Brain and Behaviour after Covid-19
It’s a very crucial topic to discuss nowadays Overall, the conference session on Brain and Behaviour After COVID-19 was a timely and important discussion on the neurological and psychological impacts of the pandemic. It highlights the need for continued research and multidisciplinary care to address the complex medical and psychological needs of individuals affected by COVID-19. The session will also underscore the need for equitable access to healthcare and mental health resources to address existing health disparities exacerbated by the pandemic.
Track 11: Epilepsy/seizures
Epilepsy is a neurological disorder characterized by recurrent seizures, which are caused by abnormal electrical activity in the brain. They will discuss the various types of seizures, including focal seizures, generalized seizures, and absence seizures and the speakers will also emphasize that epilepsy can affect individuals of all ages and that it can be caused by a variety of factors, including genetics, brain injury, and infections.
Track 12: Alzheimer’s and Dementia
Alzheimer's and Dementia are progressive disorders characterized by a decline in cognitive and memory function. The various stages of these conditions, from mild cognitive impairment to severe dementia. The speakers will also mention that these conditions are prevalent among older adults and that they can have a significant impact on the quality of life of both patients and their caregivers.
Track 13: Panic Disorder
panic disorder is a type of anxiety disorder characterized by recurrent and unexpected panic attacks. They will discuss the various symptoms of panic attacks, including heart palpitations, sweating, trembling, and shortness of breath. The speakers will also emphasize that panic disorder can have a significant impact on the quality of life of individuals affected by the condition and that it can be difficult to diagnose and treat.
Track 14: Parkinson’s Disease
Parkinson's Disease is a progressive disorder of the nervous system characterized by motor symptoms such as tremors, rigidity, and bradykinesia. The discussion includes the various non-motor symptoms of Parkinson's Disease, including cognitive impairment, depression, and sleep disorders. The speakers will also be addressed and discuss strategies to improve the quality of life for those affected by the disease.
Track 15: Personality and mental health
In this session, we will be exploring the relationship between personality and mental health, and how understanding this relationship can help us to better diagnose and treatment for mental health disorders.
Track 16: Headache and Facial pain
Headaches are a common health problem that affects millions of people worldwide. There are many different types of headaches, including tension headaches, migraines, cluster headaches, and sinus headaches. Each type of headache is characterized by different symptoms and may have different underlying causes. Facial pain can also be a symptom of many different conditions some common causes are trigeminal neuralgia, sinus, dental problems, and temporomandibular joint disorder. The speaker and experts will discuss the future research direction and potential advanced treatments.
Track 17: Social Anxiety and Sleep Disorder
Social anxiety is mental health characterized by an excessive fear of social situations and performance situations it has physical symptoms of sweating, trembling and heart palpitations. Sleep disorders are a group of conditions that affect an individual’s ability to fall asleep, stay asleep, or achieve restful sleep some common sleep disorders include, sleep apnea, and restless leg syndrome.
Track 18: Animal Model in Brain Research
The use of animal models in brain study and their uses in comprehending brain function and dysfunction will be the main topics of this conference session. Topics related to the creation of novel therapies and treatments as well as the use of animal models to research neurological and psychiatric diseases will be covered at this conference.
Topics like these will be discussed in the session:
1. The study of neurological diseases like autism and schizophrenia using animal models
2. Neurodegenerative illnesses like Alzheimer's and Parkinson's are replicated in animals.
3. The study of addiction and drug misuse using animals
4. Improvements in animal simulation methods, such as genetic engineering and optogenetics
5. Ethics of using animals as test subjects for brain study
Track 19: Psychiatric Research on Brain
The study of neurotransmitters, which are chemicals in the brain that transmit signals between neurons. Imbalances in neurotransmitters, such as serotonin, dopamine, and norepinephrine, have been linked to various mental illnesses. Psychiatric research on the brain is investigating the role of neurotransmitters in mental illness and how drugs that target these neurotransmitters can be used to treat mental health disorders under this topic will be collaborating with the speakers, Keynote speaker, and Experts in this field.
Track 20: Case studies and reports on brain health
The discussion will touch on issues related to these conditions' evaluation, management, and management, as well as their consequences for comprehending how the brain functions.
The lesson may touch on a variety of subjects, including
1. Case studies of individuals with uncommon or unique neurological or mental health issues
2. Reports on the application of novel methods for brain disorders diagnosis and therapy
3. Case studies of severe brain injury individuals and their recovery
4. Reports on how the brain changes in reaction to trauma, illness, or training
5. Case studies and accounts' implications for our knowledge of the brain's structure and function.
Track 21: Molecular Brain Research
Over the past few years, significant progress has been made in our understanding of the biochemical processes underlying brain activity. These networks regulate a wide range of functions, including memory, learning, emotion, and behaviour. One of the main areas of molecular brain science is the investigation of neurotransmitters, which are the chemical mediators that allow neurons to communicate with one another. Experts will talk about the roles of chemicals like dopamine, serotonin, and acetylcholine in different parts of the brain and how they influence behaviours.
Track 22: Movement Disorder
Movement disorders are a group of neurological conditions that affect the ability to control movement. These disorders can have a significant impact on quality of life, making it difficult to perform everyday activities such as walking, eating, and speaking. We will hear from experts in the field who will discuss the various types of movement disorders, including Parkinson's disease, Huntington's disease, dystonia, and essential tremor. They will present the latest findings on the underlying causes of these disorders, including genetic and environmental factors. We will also learn about the latest diagnostic tools and techniques, including imaging studies, electrophysiology, and genetic testing. These tools can help clinicians identify specific movement disorders and tailor treatment plans accordingly
Track 23: Brain Cancer
It can be challenging to manage brain cancer because it is a complicated condition. It can develop from different kinds of brain cells and rapidly expand to other areas of the body and the brain. We will hear from specialists who will share the most recent findings on the root causes of brain cancer, including genetic and environmental variables, during this talk. Additionally, we will explore the most recent diagnosis methods and instruments, such as imaging studies, molecular analysis, and biomarker testing. These instruments can assist doctors in identifying particular forms of brain cancer and in developing therapeutic strategies appropriately. Additionally, various brain cancer treatment choices will be reviewed.
Track 24: Nicotine
Nicotine is a highly addictive substance found in tobacco products, such as cigarettes and e-cigarettes. It can have both short-term and long-term effects on the brain, including changes in mood, attention, and cognitive function. It is also associated with a range of health problems, including heart disease, lung cancer, and other types of cancer.
In this session, we will hear from experts who will present the latest research on the mechanisms of nicotine addiction, including the role of genetics and environment. We will also discuss the latest treatments for nicotine addiction, including behavioural therapies and medications.
Track 25: Stroke
Stroke is a leading cause of death and disability worldwide. It occurs when blood flow to the brain is disrupted, either by a blocked or ruptured blood vessel. In this session, we will hear from experts who will present the latest research on the underlying causes of stroke, including genetic and environmental factors.
We will also learn about the latest diagnostic tools and techniques, including imaging studies, biomarker testing, and clinical assessment scales. These tools can help clinicians identify specific types of stroke and tailor treatment plans accordingly. Treatment options for stroke will also be discussed.
We will hear from experts who will present the latest advances in acute stroke management, including thrombolytic therapy, mechanical thrombectomy, and neuroprotective agents.
Track 26: Bio Feedback
This conference session will focus on the latest advances in biofeedback techniques and their applications in various fields. The session will cover topics related to the use of biofeedback to improve health and wellness, enhance performance, and treat a variety of medical conditions.
1. The use of biofeedback for stress management and relaxation
2. Applications of biofeedback in sports performance training and rehabilitation
3. Biofeedback for pain management and treatment of chronic conditions such as migraines and fibromyalgia
4. The role of biofeedback in treating mental health conditions such as anxiety and depression
5. Advances in biofeedback technology, including wearable devices and mobile apps
The session is intended for healthcare professionals, researchers, and practitioners in the fields of psychology, sports medicine, physical therapy, and other related disciplines. Attendees will have the opportunity to know more about the latest research findings and clinical applications of biofeedback, as well as network with experts in the field.
MARKET ANALYSIS:
The global brain health supplements market size reached USD 9.14 billion in 2022 and it is projected to hit around USD 26.13 billion by 2032, poised to grow at a CAGR of 11.07% from 2023 to 2032.
The rising cases of depression and anxiety are observed to fuel the demand for brain health supplements across the globe.
Asia Pacific is expected to expand at a CAGR of 16% from 2023 to 2032.
• The natural molecules segment holds the maximum share of the global market.
•By application, the stress and anxiety segment is the fastest-growing segment of the global market.
• By sales channel, the online stores' segment is growing at a remarkable rate between 2023 and 2032.
The rising demand for natural and organic supplements is observed as a significant factor boosting the growth of the natural molecules segment.
Market Overview
Brain well-being is improved and improved functional performance of the brain is the goal of brain health supplements.
Supplements for brain health improve concentration and attention, treat mood problems, and encourage mental relaxation.
Furthermore, it has been demonstrated that nutrients for brain health enhance cognitive ability and safeguard brain cells.
All age categories take supplements for their brain wellness.
However, due to growing mental health worries, the population of people between the ages of 30 and 50 has grown recently.
The market's producers are concentrating on creating brain health products with greater and more comprehensive cognitive advantages than ever.
The worldwide market for brain health supplements is anticipated to experience a substantial rise during the anticipated timeframe as worries about brain and mental health are rising.
Growth Factors:
The global brain health supplements market is expected to witness significant growth during the forecast period owing to the rising awareness about neurological disorders across the globe.
Increasing awareness about mental illness across the globe is expected to fuel the growth of the brain health supplements market.
Moreover, the rising cases of brain cancer, Alzheimer's, and dementia in the geriatric population are growing the demand for brain health supplements.
With the sudden increase in screen timing for children owing to the availability of electronic devices, the risks of poor concentration and disturbed brain function will likely increase in the upcoming years.
Report Scope of the Brain Health Supplements Market
|
Report Coverage |
Details |
|
Market Size in 2023 |
USD 10.15 Billion |
|
Market Size by 2032 |
USD 26.13 Billion |
|
Growth Rate from 2023 to 2032 |
CAGR of 11.07% |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2022 |
|
Forecast Period |
2023 to 2032 |
|
Segments Covered |
By Product, By Application, and By Sales Channel |
|
Regions Covered |
North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Market Dynamics:
Driver:
Availability of brain health supplements on e-commerce platforms
The global e-commerce industry is undergoing a significant shift due to growing online shopping spending. E-commerce websites and platforms offering brain health supplements boost sales by driving the market growth. In response to COVID-19, e-commerce platforms are selling brain supplements more frequently.
The Nutritional Business Journal reports that consumers will continue to buy health supplements through e-commerce platforms. As a result, e-commerce platforms will provide significant long-term benefits to the global brain health supplement market.
Restraint:
Severe side effects of brain health supplements
Brain health supplements can cause serious side effects, such as high blood pressure, weight gain, sedation, and insomnia, and can even lead to addiction. They are not advised for pregnant or nursing women and can cause short-term side effects such as rashes on the skin, shortness of breath, and diarrhea. These side effects hinder the market's growth by changing consumer behavior.
Opportunity:
Increasing focus on improving the flavor and texture of brain health supplements
Enhancing the flavor and texture of brain health supplements is an opportunity for manufacturers to increase demand and make them more appealing and acceptable to a wide range of consumers. Factors such as the form and availability of nutritional ingredients, flavor, and texture are key factors that drive purchasing decisions. Color-masking technology can also be used to improve the flavor of supplements, thus boosting the demand.
Covid-19 Impacts:
The Covid-19 pandemic has positively impacted the global brain health supplements market, as it increased awareness of a healthy lifestyle and improved mental health. However, excessive screen timing has led to poor focus and disturbed mental health, while online gaming, schooling, and lectures have also gained screen timing for children. As a result, the population has demanded smart supplements to improve brain function and maintain brain health. Research and development activities are conducted to bring new products to the market.
Regional Insights:
The brain health supplements market dominates the North American market, with a share of over 41% in the global market. The growth of the market is attributed to rising cases of major depression and bipolar disorder, as well as the increased focus on neurological health in recent years. Asia Pacific is expected to grow at a CAGR of 16% during the forecast period due to improved healthcare and pharmaceutical industries, while Europe is also attractive for its well-established healthcare infrastructure. According to NHS England, 18% of children and 22% of adults had mental health issues in England in 2022, leading to increased demand for brain health supplies.
By Product
•Natural Molecules
O Acetyl-L-Carnitine
o Alpha GPC
o Citicoline
o DHA
o Pre/Pro/Postbiotics
•Herbal Extract
O Curcumin
O Ginseng
O Gingko Biloba
O Others
•Vitamins and Minerals
O Vitamin B
O Vitamin C & E
By Application
•Attention & Focus
•Memory Enhancement
•Sleep Recovery
•Stress & Anxiety
•Anti-ageing & Longevity
•Depression & Mood
By Sales Channel
•Drug Stores
•Supermarkets
•Online Stores
•Others
By Geography
•North America
•Europe
•Asia-Pacific
•Latin America
•The Middle East and Africa
